Related references
Note: Only part of the references are listed.ISIS-DME - A prospective, randomized, dose-escalation intravitreal steroid injection study for refractory diabetic macular edema
Judy E. Kim et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2008)
Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study)
L. Paccola et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2008)
Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy
Robert L. Avery et al.
OPHTHALMOLOGY (2006)
Intravitreal triamcinolone for refractory diabetic macular edema - Two-year results of a double-masked, placebo-controlled, randomized clinical trial
Mark C. Gillies et al.
OPHTHALMOLOGY (2006)
Diabetic retinopathy: The latest in current management
Abdhish R. Bhavsar
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2006)
Glucocorticoid regulation of endothelial cell tight junction gene expression: Novel treatments for diabetic retinopathy
EA Felinski et al.
CURRENT EYE RESEARCH (2005)
Evaluation of coupled convective-diffusive transport of drugs administered by intravitreal injection and controlled release implant
J Park et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Risks of intravitreous injection: A comprehensive review
RD Jager et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2004)
Ocular pharmacokinetics of fluocinolone acetonide after Retisert™ intravitreal implantation in rabbits over a 1-year period
JY Driot et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2004)
Diabetic retinopathy and diabetic macular edema - Pathophysiology, screening, and novel therapies
TA Ciulla et al.
DIABETES CARE (2003)
Computer simulation of convective and diffusive transport of controlled-release drugs in the vitreous humor
MS Stay et al.
PHARMACEUTICAL RESEARCH (2003)
Share Paper
